These tumours also exhibited an increase in E-cadherin expression and a reduction in Vimentin expression in xenografts derived from PinX1 overexpression nasopharyngeal CD133+ CSCs, while the expression levels were reversed by co-inhibition of miR-200b via immunohistochemistry (Fig. 6f). The gene discussed is PINX1; the disease is neoplasm.